flux by CGP 37157 (7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one) that precludes the mitochondrial Na ؉ /Ca 2؉ exchanger as well as by mitochondrial depolarization using a mixture of oligomycin and antimycin A. In contrast, after the removal of the agonist, ER refilling was found to be
Endoplasmic reticulum (ER) Ca
2؉ refilling is an active process to ensure an appropriate ER Ca 2؉ content under basal conditions and to maintain or restore ER Ca 2؉ concentration during/after cell stimulation. The mechanisms to achieve successful ER Ca 2؉ refilling are multiple and built on a concerted action of processes that provide a suitable reservoir for Ca 2؉ sequestration into the ER. Despite mitochondria having been found to play an essential role in the maintenance of capacitative Ca 2؉ entry by buffering subplasmalemmal Ca 2؉ , their contribution to ER Ca 2؉ refilling was not subjected to detailed analysis so far. Thus, this study was designed to elucidate the involvement of mitochondria in Ca 2؉ store refilling during and after cell stimulation. ER Ca 2؉ refilling was found to be accomplished even during continuous inositol 1,4,5-trisphosphate (IP 3 ؉ /Ca 2؉ exchanger as well as by mitochondrial depolarization using a mixture of oligomycin and antimycin A. In contrast, after the removal of the agonist, ER refilling was found to be largely independent of trans-mitochondrial Ca 2؉ flux. Under these conditions, ER Ca 2؉ refilling took place even without an associated Ca 2؉ elevation in the deeper cytosol, thus, indicating that superficial ER domains mimic mitochondrial Ca 2؉ buffering and efficiently sequester subplasmalemmal Ca 2؉ and consequently facilitate capacitative Ca 2؉ entry. Hence, these data point to different contribution of mitochondria in the process of ER Ca 2؉ refilling based on the presence or absence of IP 3 , which represents the turning point for the dependence or autonomy of ER Ca 2؉ refilling from trans-mitochondrial Ca 2؉ flux.
For a large number of receptors, the binding of the respective agonist initiates the generation of inositol 1,4,5-trisposphate (IP 3 ), 1 which in turn triggers Ca 2ϩ release from the endoplasmic reticulum (ER), leading to an instant rise of the cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] cyto ). This elevation in [Ca 2ϩ ] cyto is subsequently maintained by adjusting the activity of Ca 2ϩ -permeable ion channels, pumps, exchangers, and buffer systems (for review see Refs. 1 and 2). To ensure that, even under repetitive stimulations a suitable intracellular Ca 2ϩ release is possible refilling of the main intracellular Ca 2ϩ store, the ER has to be accomplished either while balancing high levels of [Ca 2ϩ ] cyto during cell stimulation or at least during the decay of cell stimulation.
The mechanisms to achieve successful ER Ca 2ϩ refilling are multiple and built on a concerted action of many processes that provide a suitable reservoir for Ca 2ϩ sequestration via the ER Ca 2ϩ pumps (SERCAs). Because elevated cytosolic Ca 2ϩ is also substrate for Ca 2ϩ extrusion mechanisms such as the plasma membrane Ca 2ϩ ATPases or the Na ϩ /Ca 2ϩ exchanger (NCX pm ), Ca 2ϩ entry through the plasma membrane takes place in order to preclude a life-threatening loss of cellular Ca 2ϩ . At least in non-excitable cells, the firmly established phenomenon of capacitative Ca 2ϩ entry (CCE) (3), which is activated by the emptying of intracellular Ca 2ϩ stores, accounts for Ca 2ϩ transit through the plasma membrane (4 -6). Although the mechanisms of activation of the non-voltage gated Ca 2ϩ -permeable ion channel(s) that account for CCE (e.g. Refs. 7-11) and its/their molecular nature are still under debate (12) (13) (14) , recent investigations point to a fundamental role of mitochondria in the maintenance (15-19) and modulation (20) of the CCE in many cell types. Notably, the intriguing aptitude of mitochondria to effectively impound subplasmalemmal Ca 2ϩ (i.e. mitochondrial Ca 2ϩ -buffering function) was found to be pivotal for the maintenance of the CCE pathway as they prevent Ca 2ϩ -dependent inactivation of the CCE channel(s) (15, 19, 21 (25) .
EXPERIMENTAL PROCEDURES
Materials-Cell culture chemicals were from Invitrogen, and fetal calf serum was obtained from PAA Laboratories (Linz, Austria). Fura-2/AM was from Molecular Probes Europe (Leiden, Netherlands). CGP 37157 was purchased from Tocris Cookson Ltd. (Northpoint, Avonmouth, Bristol, United Kingdom). Histamine, BHQ, EGTA, oligomycin, and antimycin A were from Sigma-Aldrich (Vienna, Austria). Restriction enzymes and T4 DNA ligase were from New England BioLabs (Frankfurt, Germany), and the EndoFree Plasmid Maxi Kit was from Qiagen. All of the other chemicals were from Roth (Karlsruhe, Germany).
Cell Culture-The human umbilical vein endothelial cell line, EA.hy926 passage Ն45, was used for this study. Cells were cultured in Dulbecco's minimum essential medium containing 10% fetal calf serum and 1% HAT (5 mM hypoxanthine, 20 M aminopterin, 0.8 mM thymidine). For experiments, cells were grown on glass coverslips (24 or 30 mm).
Plasmids and Transfection-For transfection, an improved version of the YC4-ER (26, 27) , vYC4-ER (28), and RP-mt (29) in pcDNA 3 (Invitrogen) was used. Cells (ϳ80% confluency) were transiently transfected with 1.5-3 g of purified plasmid DNA using TransFast TM transfection reagent (Promega, Mannheim, Germany). Between 24 and 36 h after transfection, cells were used for the experiments. To monitor [Ca 2ϩ ] mito , an EA.hy926 cell line that stably expresses RP-mt was also used, which provided virtually identical results to those obtained in cells transiently transfected with RP-mt.
Solutions-Dye loading was performed with a loading buffer solution containing 2 mM CaCl 2 , 135 mM NaCl, 1 mM MgCl 2 , 5 mM KCl, 10 mM Hepes, 2.6 mM NaHCO 3 , 0.44 mM KH 2 PO 4 , 10 mM D-glucose, 0.1% vitamins, 0.2% essential amino acids, 1% penicillin/streptomycin, and 1% fungizone, pH adjusted to 7.4, with NaOH. The Ca 2ϩ containing experimental buffer was composed of (in mM) 145 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 D-glucose, and 10 Hepes acid, pH adjusted to 7.4, with NaOH. In experiments where a Ca 2ϩ -free solution was applied to the cells, Ca 2ϩ -free experimental buffer containing 1 mM EGTA was used. Imaging Device-Our setup for monitoring cytosolic and organelle Ca 2ϩ signaling was described previously (24) . All of the Ca 2ϩ measurements were performed at room temperature on a Nikon inverted microscope (Eclipse 300 TE, Nikon, Vienna, Austria) equipped with an epifluorescence system (150 W XBO, Optiquip, Highland Mills, NY) using the Plan Fluor ϫ40 oil immersion objective from Nikon. Excitation filters were changed with a Ludl filter-wheel device (Ludl Electronic Products, Hawthorne, NY). Fluorescence was monitored with a cooled CCD camera (Ϫ30°C; Quantix KAF 1400G2, Roper Scientific, Acton, MA). All of the devices were controlled by the MetaFluor® 4.0 software (Universal Imaging, Visitron Systems, Puchheim, Germany). The glass coverslips were mounted into an experimental chamber, and cells were perfused with experimental buffer at a rate of ϳ1.5 ml/min. The perfusion system allowed fast buffer exchange from seven reservoirs.
Cytoslic Ca 2ϩ Measurements-Changes in [Ca 2ϩ ] cyto were monitored using the Ca 2ϩ -sensitive dye fura-2 (24). Cells were loaded for 45 min at room temperature in the dark in loading buffer containing 2 M Fura-2/AM. Prior experiments, cells were washed twice with loading buffer and equilibrated for an additional 30 min in the same buffer in the dark. Cells were illuminated alternatively at 340 Ϯ 15 and 380 Ϯ 15 nm (340HT15 and 380HT15; Omega Optical, Brattleboro, VT), and emission was monitored at 510 nm (510WB40, Omega Optical (19, 28) . Notably, RP-mt was demonstrated to be a reliable Ca 2ϩ sensor when excited at 410 -440 nm, whereas the fluorescence of the permutated yellow fluorescent protein reflects mainly changes in the H ϩ concentration (30) when excited at 480 nm. Therefore, in contrast to our previous work (19) , in this study, RP-mt was only excited at 433 nm (433DF15, Omega Optical) and emission was collected at 535 nm (535AF26, Omega Optical). Thus, [Ca 2ϩ ] mito was expressed as 1 Ϫ F 430 /F 0 as previously shown (30) .
[Ca 2ϩ ] er Measurements-The improved version of the original YC4-ER (26, 27) , vYC4-ER (28), was used to monitor the free Ca 2ϩ concentration within the ER lumen. This Ca 2ϩ sensor was excited at 440 Ϯ 21 nm (440AF21, Omega Optical), and emission was collected simultaneously at 535 and 480 nm with one given camera using an optical beam splitter (535 and 480 nm, Dual-View MicroImager TM , Optical Insights, Visitron Systems) as described previously (19, 24) . To correct the decay in the F 535 /F 480 ratio during the experiments, which was probably due to photobleaching or photochromism of vYC4-ER, the changes of the ER Ca 2ϩ concentration were expressed as (F 535 /F 480 )/F 0 .
Statistics-Analysis of variance (ANOVA) and Scheffe's post hoc F test were used for evaluation of the statistical significance. p Ͻ 0.05 was defined to be significant.
RESULTS

ER Ca
2ϩ Refilling Is Only Moderately Affected by IP 3 -As published recently (19) , the removal of extracellular Ca 2ϩ during stimulation with histamine accelerated the rate of ER Ca 2ϩ depletion in endothelial cells, whereas Ca 2ϩ re-addition yielded a rapid Ca 2ϩ refilling of the ER (Fig. 1) . Notably, the kinetics of ER Ca 2ϩ refilling upon the addition of extracellular Ca 2ϩ was similar in the presence and absence of the IP 3 -generating autacoid. However, under conditions where histamine was washed out prior to Ca 2ϩ re-addition, the ER Ca 2ϩ content was completely restored to initial values, whereas in the presence of histamine, the ER refilled up to the level prior to the removal of extracellular Ca 2ϩ (Fig. 1 ). These data indicate that, in Fig. 2A, both panels) .
In the presence of histamine, the re-addition of Ca 2ϩ yielded a fast and instant rise in [Ca 2ϩ ] mito ( Fig. 2A, left panel) , whereas in the absence of histamine, mitochondrial Ca 2ϩ elevation upon Ca 2ϩ re-addition developed at a slower pace ( Fig.  2A, right panel) .
To investigate the impact of the major Ca 2ϩ export pathway from mitochondria (the NCX mito ), CGP 37157, a specific inhibitor of NCX mito (31, 32) , was used. CGP 37157 (20 M) had no effect on [Ca 2ϩ ] mito under basal conditions. In contrast, upon cell stimulation, NCX mito inhibition lead to a long-lasting elevation of [Ca 2ϩ ] mito that could be reduced neither by the removal of extracellular Ca 2ϩ ( Fig. 2A, both panels) nor by agonist washout ( Fig.  2A, right panel) . In the presence of CGP 37157, the re-addition of Ca 2ϩ had no further effect on [Ca 2ϩ ] mito independently of the agonist ( Fig. 2A, both panels) , indicating that the capacity of mitochondria to sequester Ca 2ϩ has been saturated under these conditions. This is in line with our previous report (19) (Fig. 2B, left panel) . However, cytosolic Ca 2ϩ elevation upon Ca 2ϩ re-addition after histamine washout was fast but transient (Fig. 2B, right panel) . Thus, in the presence of histamine, Ca 2ϩ entry yielded a similar profile of Ca 2ϩ elevation in the cytosol and the mitochondria, whereas in the absence of the agonist, the response differed between both compartments.
Remarkably, the importance of trans-mitochondrial Ca 2ϩ flux for cytosolic Ca 2ϩ elevation also depended on the presence of histamine. Notably, inhibition of NCX mito with CGP 37157 reduced the cytosolic Ca 2ϩ elevation upon re-addition of extracellular Ca 2ϩ in the presence of histamine by ϳ40% (Fig. 2B,  left panel) . A detailed analysis of the Ca 2ϩ entry kinetics in the presence of histamine revealed that CGP 37157 reduced the rate of the initial Ca 2ϩ elevation upon Ca 2ϩ re-addition by ϳ90%, whereas a continuous cytosolic Ca 2ϩ elevation developed slowly (Fig. 2C, left panel) . However, the inhibitory effect of CGP 37157 was much more pronounced if histamine was removed prior to Ca 2ϩ re-addition (Fig. 2B , right panel) and no subsequent slow continuous Ca 2ϩ elevation occurred (Fig. 2C,  right panel) . These data indicate that, in the presence of IP 3 , blocking NCX mito modestly affects cytosolic Ca 2ϩ elevation upon Ca 2ϩ re-addition (Fig. 2D, left panel) , which might be due to Ca 2ϩ release from partially refilled ER in the presence of histamine. However, after histamine washout, trans-mitochondrial Ca 2ϩ flux is required to allow cytosolic Ca 2ϩ elevation (Fig. 2D, right panel) and, thus, under these conditions the ER does not contribute to cytosolic Ca 2ϩ elevation. To confirm this hypothesis, SERCA activity was blocked with 15 M BHQ during Ca 2ϩ re-addition in the presence of histamine. In the absence of CGP 37157, SERCA inhibition slightly enhanced cytosolic Ca 2ϩ elevation upon Ca 2ϩ re-addition (Fig.  3) . However, in the presence of the NCX mito inhibitor, cytosolic Ca 2ϩ elevation upon Ca 2ϩ re-addition was strongly affected by BHQ (Fig. 3) . These data point to a Ca 2ϩ cycling across the ER in the presence of IP 3 and partially filled ER stores and/or to the contributory role of ER Ca 2ϩ buffering to the regulation of plasma membrane Ca 2ϩ entry. To approve our data with CGP 37157, identical Ca 2ϩ readdition protocols were accomplished in the presence of 2 M oligomycin and 10 M antimycin A. As shown in Fig. 4A , cell treatment with the mixture of oligomycin/antimycin A reduced histamine-induced [Ca 2ϩ ] mito elevation by ϳ83%. Nevertheless, mitochondrial Ca 2ϩ decreased upon the removal of extracellular Ca 2ϩ even in the presence of oligomycin/antimycin A, indicating that Ca 2ϩ still moved through mitochondria despite their depolarization (Fig. 4A) . However, similar to the data with CGP 37157 presented above (i.e. Fig. 2B ), the inhibitory effect of oligomycin/antimycin A on cytosolic Ca 2ϩ elevation upon Ca 2ϩ re-addition was more pronounced after histamine washout (Fig. 4, B and C) .
Overall, these data suggest that the presence of an IP 3 -generating agonist not only affects mitochondrial Ca 2ϩ handling of entering Ca 2ϩ but also modulates the contribution of trans-mitochondrial Ca 2ϩ flux for cytosolic Ca 2ϩ elevation. Considering such striking differences in the pathways for cytosolic Ca 2ϩ elevation upon Ca 2ϩ re-addition in prestimulated cells, the modus operandi to accomplish ER Ca 2ϩ refilling in the presence and absence of IP 3 were investigated. 
Mitochondria and ER Ca 2ϩ RefillingRoute and Source of Ca 2ϩ for ER Refilling Differ Depending on the Presence or Absence of an Agonist-Inhibition of NCX mito strongly reduced ER Ca
2ϩ refilling in the presence of the agonist (Fig. 5, A, left panel, and C) . In contrast, the inhibition of NCX mito in the absence of the agonist only marginally reduced ER Ca 2ϩ refilling (Fig. 5, B , left panel, and C), despite the strong inhibition (ϳ83%) of the cytosolic Ca 2ϩ signaling by CGP 37157 (Fig. 2D, right panel) . In line with these findings, oligomycin/antimycin A attenuated ER Ca 2ϩ refilling more efficiently in the presence of histamine than in its absence (Fig.  5C, right panel) .
These data suggest that, in the presence of IP 3 that could be released by a second stimulation with histamine, although [Ca 2ϩ ] cyto elevation upon Ca 2ϩ re-addition was reduced by Ͼ80% in the presence of CGP 37157 (20 M) (Fig. 6, A and B) or oligomycin/antimycin A (2 M/10 M) (Fig. 6B) .
These data indicate that, in the absence of the agonist, ER Ca 2ϩ refilling is achieved independently of trans-mitochondrial Ca 2ϩ flux and cytosolic Ca 2ϩ elevation. Thus, in the absence of IP 3 , ER refills directly via the ER-plasma membrane junction (i.e. SCCU) (33, 34) and, thus, represents a mitochondria-independent phenomenon. However, in the presence of IP 3 concentration during/after cell stimulation. In this paper, the mechanisms of such Ca 2ϩ storerefilling procedures and the contribution of mitochondria to these processes were elucidated (Fig. 7) . Remarkably, ER Ca 2ϩ refilling was found to be efficiently accomplished even during continuous IP 3 -triggered ER Ca 2ϩ release in the presence of an agonist. ER Ca 2ϩ refilling depended essentially on the presence of extracellular Ca 2ϩ as the source and SERCA activity, which sequesters entering Ca 2ϩ into the ER (19) . Moreover, the present data point to differences in the mitochondrial contribution to ER Ca 2ϩ refilling that are based on IP 3 , which represents the turning point for the dependence or autonomy of ER Ca 2ϩ refilling from trans-mitochondrial Ca 2ϩ flux. Notably, in the presence of IP 3 , which continuously achieves elevation of subplasmalemmal Ca 2ϩ concentration in the vicinity of the ER (i.e. SCCU) (22, 24) and, thus, prevents the Ca 2ϩ -inhibitable CCE pathway/channel, ER Ca 2ϩ refilling crucially depends on transmitochondrial Ca 2ϩ flux as this organelle efficiently buffers subplasmalemmal Ca 2ϩ and therefore facilitates CCE (Fig.  7A) . In contrast, after the removal of the IP 3 -generating agonist, ER-refilling was found to be independent of mitochondrial Ca 2ϩ -buffering capacity and cytosolic Ca 2ϩ elevation but might occur directly at the junctions between the ER and the plasma membrane (Fig. 7B) .
ER Ca 2ϩ Dynamics in Endothelial Cells-In the endothelial cells used in this study, the ER Ca 2ϩ content remained unchanged even in the absence of extracellular Ca 2ϩ . In contrast, in HeLa cells, the removal of extracellular Ca 2ϩ results in an instant decline in [Ca 2ϩ ] er because of passive Ca 2ϩ leak from the ER that cannot be compensated under these conditions (35) . Thus, while in HeLa cells, a constant transfer of extracellular Ca 2ϩ toward the ER is necessary to maintain the filling state of the ER under basal condition, endothelial cells, at least for a time period of up to 5 min, are able to preserve the ER Ca 2ϩ content independently of extracellular Ca 2ϩ (36) . However, our findings that histamine-induced ER Ca 2ϩ depletion was much more pronounced in the absence of extracellular Ca 2ϩ than in its presence indicate that, during agonist stimulation, ER Ca 2ϩ refilling in endothelial cells crucially depends on the influx of Ca 2ϩ from the extracellular compartment. These data are in agreement with those found in HeLa cells 
Mitochondria and ER Ca 2ϩ Refilling
but in contrast to those found in human embryonic kidney 293 cells where the extent of agonist-induced ER depletion was equal in the presence or absence of extracellular Ca 2ϩ (37) . However, while in these cell lines, large ER depletion became visible only in the presence of a SERCA inhibitor, whereas agonists had only little impact on the [Ca 2ϩ ] er in endothelial cells, the extent of agonist-achievable ER depletion in the absence of extracellular Ca 2ϩ is far higher and equals that of a SERCA inhibitor (19) .
Interestingly, the kinetics of ER Ca 2ϩ refilling did not differ if the agonist was present or not, and upon addition of extracellular Ca 2ϩ , the ER Ca 2ϩ content was restored up to the level prior to its removal (Fig. 1 (Fig. 7A) . Hence, such continuous Ca 2ϩ release from a partially refilled ER in the presence of histamine would explain the slow cytosolic Ca 2ϩ elevation upon Ca 2ϩ re-addition in the presence of CGP 37157 (Fig. 2B, left panel) . This suggestion is further supported by our findings that an inhibition of SERCA by BHQ prevented this slow rise of [Ca 2ϩ ] cyto (Fig. 3) . In addition, these findings may reflect the contribution of ER Ca 2ϩ buffering to the maintenance of the activity of Ca 2ϩ entry. (19) . Thus, once ER Ca 2ϩ refilling is completed, the secondary rise in [Ca 2ϩ ] mito might point to a reduced mitochondrial Ca 2ϩ efflux due to the lack of this negative Ca 2ϩ gradient. However, our data that repetitive histamine stimulation achieved identical intracellular Ca 2ϩ release independent of whether or not CGP 37157 or oligomycin/antimycin A was present during the Ca 2ϩ re-addition phase (Fig. 6 ) indicate that ER Ca 2ϩ refilling is accomplished independently of mitochondrial Ca 2ϩ homeostasis. These surprising findings further suggest that, in the absence of an agonist, ER Ca 2ϩ refilling is largely independent of the cytosolic Ca 2ϩ concentration, and our findings were confirmed by the negligible effect of CGP 37157 or oligomycin/antimycin A on ER Ca 2ϩ refilling measured with vYC4-ER (Fig. 5) .
These data indicate that, after removal of the IP 3 -generating agonist, ER refilling is achieved independently of mitochondria and cytosolic Ca 2ϩ elevation and may occur directly at the junction between the ER and the facing plasma membrane CCE channels (Fig. 7B) . Thus, in agreement with previous reports (e.g. Ref. 41) , in the absence of ER Ca 2ϩ release, emptied superficial ER domains might mimic mitochondrial Ca 2ϩ buffering and facilitate the maintenance of CCE by sequestering subplasmalemmal Ca 2ϩ into the ER lumen in order to accomplish ER refilling independently from mitochondria and Ca 2ϩ concentration in the deeper cytosol. These data are in line with the initial superficial Ca 2ϩ buffer barrier concept, introduced by the VanBreemen group, in smooth muscle cells (42) (43) (44) (45) and might indicate that this landmark concept is also valid in endothelial cells.
In conclusion, this work suggests that ER Ca 2ϩ refilling is accomplished even in the presence of an IP 3 -generating agonist. Furthermore, the contribution of mitochondria to cellular Ca 2ϩ homeostasis is modulated extensively by IP 3 (Fig. 6 ). Herein we report that, in the absence of IP 3 , the ER refills upon Ca 2ϩ re-addition independently of the mitochondria by sequestrating entering Ca 2ϩ in the subplasmalemmal area between the ER and the plasma membrane. In the presence of IP 3 
